Explore published articles and webinars from Litmys leaders that spotlight new thinking and practical approaches to achieving market success across the life sciences.
What determines whether a breakthrough therapy becomes a commercial success? In this Citeline In Vivo podcast, Harris Kaplan joins former Kite Pharma executive Diane Parks and CAR-T patient Jim Haag to discuss the launch of Yescarta and the critical role that stakeholder adoption, market access, and real-world implementation play in translating scientific innovation into lasting impact.
